V676 Lab services patients need, from a part 493 lab
Written V0676 on the CMS-2567 and in QCOR.
Cited on this tag? What happens after a citation · One-page sheet for the binder
The regulation
§ 494.130 – The dialysis facility must provide or make available, laboratory services (other than tissue pathology and histocompatibility) to meet the needs of the ESRD patient. Any laboratory services, including tissue pathology and histocompatibility must be furnished by or obtained from, a facility that meets the requirements for laboratory services specified in part 493 of this chapter.
Appendix H quotes this text a little differently from the regulation as published today. The eCFR has the current wording.
CMS's interpretive guidance
Interpretive Guidance § 494.130
Under Clinical Laboratory Improvement Amendments of 1988 (CLIA), laboratory services can only be provided by an appropriately certified laboratory. Arrangements with these providers must be in writing and signed and should specify: the types of laboratory tests to be performed; methods for collection and handling the specimen(s); and, delivering results, including a timeline for reporting of “alert” (sometimes called “panic”) values to a responsible person.
Many facilities have agreements with distant laboratories for routine services; there should also be a provision for service from a local laboratory for time-sensitive testing.
The dialysis facility may provide some testing directly. Generally, this is limited to CLIA-waived tests, such as for blood glucose determinations obtained by blood glucose monitoring devices cleared by FDA specifically for home use, and for stool testing for occult blood.
HLA Laboratories performing Panel Reactive Antibody (PRA) testing for patients on the transplant waitlist must have a “regular” CLIA certificate of compliance or certificate of accreditation which allows the laboratory to perform high-complexity testing.
Laboratory reports should be included in facility records and should include the patient’s name and identifier, the date and time the specimen was taken, and the name and address of the laboratory performing the test. Facility policies should address methods for specimen collection, especially pertaining to post-dialysis samples for dialysis adequacy testing to ensure accurate results.
https://middlemolecule.com/rulebook/tags/v676/